Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.36 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.36 |
| ▸ | FPR1 | P21462 | 1/20 | 0.35 |
| ▸ | FPR2 | P25090 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.35 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL8870694 | 0.96 | TP53 (0.47) | TP53SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL659817 | 0.92 | TP53 (0.50) | TP53SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL16438180 | 0.92 | TP53 (0.50) | TP53SLC7A5SLC1A3SLC1A2SLC1A1 | |
| Acetic Acid SCHEMBL28467894 | 0.90 | FFAR3 (0.44) | TP53SLC7A5SLC1A3SLC1A2SLC1A1 | |
| Propene SCHEMBL27948180 | 0.85 | TP53 (0.38) | TP53SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL17049853 | 0.83 | TP53 (0.42) | TP53SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL2297452 | 0.83 | TP53 (0.50) | TP53SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL15592505 | 0.83 | TP53 (0.50) | TP53SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL15113031 | 0.83 | TP53 (0.42) | TP53SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL28263618 | 0.83 | TP53 (0.50) | TP53SLC7A5SLC1A3SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 295 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111926307-B | Method for manufacturing graphene film, porous silicon dioxide powder and transparent conducting layer | 北海惠科光电技术有限公司 | 2023-04-07 | — | — | CN | claimed |
| EP-3914605-B1 | PEPTIDE PRECIPITATION METHOD | DSM IP ASSETS BV (NL) | 2022-12-07 | — | — | EP | claimed |
| EP-3914605-A1 | PEPTIDE PRECIPITATION METHOD | DSM IP Assets B.V. (NL) | 2021-12-01 | — | — | EP | claimed |
| CN-113330021-A | Peptide precipitation method | 帝斯曼知识产权资产管理有限公司 | 2021-08-31 | — | — | CN | claimed |
| CN-110316726-B | Graphene nanowire film, preparation method thereof and thin film transistor array | 惠科股份有限公司 | 2021-07-02 | — | — | CN | claimed |
| CN-112680719-A | Graphene film, preparation method thereof and thin film transistor array | 北海惠科光电技术有限公司 | 2021-04-20 | — | — | CN | claimed |
| EP-2903979-B1 | NOVEL COMPOUNDS, THEIR PREPARATION AND THEIR USES | INHIBIKASE THERAPEUTICS INC (US) | 2020-08-19 | — | — | EP | claimed |
| WO-2020152246-A1 | PEPTIDE PRECIPITATION METHOD | DSM IP ASSETS B.V. (NL) | 2020-07-30 | — | — | WO | claimed |
| WO-2020148787-A1 | ENANTIOSELECTIVE SYNTHESIS OF BRIVARACETAM AND INTERMEDIATES THEREOF | CLININVENT RESEARCH PVT. LTD. (IN) | 2020-07-23 | — | — | WO | claimed |
| EP-3088955-B1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHINETSU CHEMICAL CO (JP) | 2020-06-03 | — | — | EP | claimed |
| WO-2009074574-A1 | METHOD FOR PRODUCING ISOPROPANOL AND 2-BUTANOL FROM THE CORRESPONDING ALKANES | BASF SE (DE) | 2009-06-18 | — | — | WO | claimed |
| US-7199144-B2 | Process for the preparation of valsartan and intermediates thereof | TEVA PHARMACEUTICALS INDUSTRIES, LTD. (IL) | 2007-04-03 | — | — | US | claimed |
| US-20060004098-A1 | Compounds useful for treating neurological disorders | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2006-01-05 | — | — | US | claimed |
| EP-1556363-A2 | PROCESS FOR THE PREPARATION OF VALSARTAN AND INTERMEDIATES THEREOF | Teva Pharmaceutical Industries Limited (IL) | 2005-07-27 | — | — | EP | claimed |
| US-20050059827-A1 | Process for the preparation of valsartan and intermediates thereof | TEVA PHARMACEUTICALS INDUSTRIES LTD. (IL) | 2005-03-17 | — | — | US | claimed |
| WO-2004094391-A2 | PROCESS FOR THE PREPARATION OF VALSARTAN AND INTERMEDIATES THEREOF | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2004-11-04 | — | — | WO | claimed |
| US-20030212131-A1 | Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, a method for their synthesis and pharmaceutical compositions containing them | BIALER MEIR (IL) | 2003-11-13 | — | — | US | claimed |
| US-20030036489-A1 | Consumable composition comprising perfumed particles and article containing the same | THE PROCTER & GAMBLE COMPANY | 2003-02-20 | — | — | US | claimed |
| WO-2002090479-A1 | PERFUMED PARTICLES AND ARTICLES CONTAINING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| WO-2002090481-A1 | COMPOSITIONS AND ARTICLES FOR EFFECTIVE DEPOSITION OF PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050059827-A1 | Process for the preparation of valsartan and intermediates thereof | REN, AGT, ACE | TP53 3982/4885SLC7A5 1766/4885SLC1A3 2202/4885 |
| US-20030212131-A1 | Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, a method for their synthesis and pharmaceutical compositions containing them | ADCYAP1R1, GRIN2A, PTGER1 | TP53 4058/4885SLC7A5 3003/4885SLC1A3 659/4885 |
| US-20060004098-A1 | Compounds useful for treating neurological disorders | GAP43, CLN6, NLN | TP53 4873/4885SLC7A5 2983/4885SLC1A3 169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.